<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03107169</url>
  </required_header>
  <id_info>
    <org_study_id>IF14-005</org_study_id>
    <nct_id>NCT03107169</nct_id>
  </id_info>
  <brief_title>Treatment of Initial Clostridium Difficile Infection</brief_title>
  <official_title>Fecal Microbiota Transplant Versus Vancomycin for Treatment of Initial Clostridium Difficile Infection</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Universidad Autonoma de Nuevo Leon</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Universidad Autonoma de Nuevo Leon</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Investigators designed an open, two-arm study to compare oral vancomycin with a fecal
      microbiota transplant (FMT) from a fecal donor-unrelated donor mix (FURM) as treatments for
      the first Clostridium difficile infection (CDI) episode among hospitalized patients.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Investigators designed an open, two-arm study to compare oral vancomycin with an FMT-FURM as
      treatments for the first Clostridium difficile infection (CDI) episode among hospitalized
      patients. From each patient, a fecal sample was obtained at days 0, 3, and 7 after treatment.
      Specimens are cultured to isolate C. difficile, and C. difficile are assessed for the
      presence of genes encoding enterotoxin (tcdB), cytotoxin (tcdA), the binary toxin A (cdtA),
      binary toxin B (cdtB), and deletions within the negative regulator of toxin A and B
      production (tcdC) by polymerase chain reaction (PCR). The minimum inhibitory concentrations
      (MICs) of ciprofloxacin, moxifloxacin, erythromycin, clindamycin, vancomycin, metronidazole,
      linezolid, fidaxomicin, and tetracycline against C. difficile are measured using the agar
      dilution method. Fecal samples and FMT-FURM are analyzed by 16 subunit ribosomal ribonucleic
      acid (16S rRNA) metagenomic sequencing.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">February 1, 2015</start_date>
  <completion_date type="Actual">September 30, 2015</completion_date>
  <primary_completion_date type="Actual">September 30, 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Participant)</masking>
    <masking_description>Patients were randomized by a closed envelope method in a 1: 1 ratio to either oral vancomycin (every 6 h for 10-14 days) or a FMT-FURM</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Decrease in number of evacuations</measure>
    <time_frame>up to a 2 days</time_frame>
    <description>The cure of CDI was measured</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">10</enrollment>
  <condition>Clostridium Difficile Infection</condition>
  <arm_group>
    <arm_group_label>Vancomycin</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Patients in this arm received vancomycin 250mg every 6 hrs for 10-14 days</description>
  </arm_group>
  <arm_group>
    <arm_group_label>FMT-FURM</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients in this arm receive FMT-FURM</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>FMT</intervention_name>
    <description>Patients in the FMT group received FMT-FURM</description>
    <arm_group_label>FMT-FURM</arm_group_label>
    <other_name>fecal microbiota transplant</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Vancomycin</intervention_name>
    <description>Patients in the vancomycin group received oral vancomycin (250 mg every 6 h for 10-14 days)</description>
    <arm_group_label>Vancomycin</arm_group_label>
    <other_name>Glycopeptide</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Clinical diagnosis of CDI (first episode)

          -  Older than 18 years old

        Exclusion Criteria:

          -  Patients younger than 18 years old
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <verification_date>April 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 21, 2017</study_first_submitted>
  <study_first_submitted_qc>April 10, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">April 11, 2017</study_first_posted>
  <last_update_submitted>April 15, 2017</last_update_submitted>
  <last_update_submitted_qc>April 15, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">April 18, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Universidad Autonoma de Nuevo Leon</investigator_affiliation>
    <investigator_full_name>Adri√°n Camacho-Ortiz</investigator_full_name>
    <investigator_title>Dr.</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Infection</mesh_term>
    <mesh_term>Communicable Diseases</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Vancomycin</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

